Follow
In Vivo
In Vivo: are those in which the effects of various biological entities are tested on whole, living organisms or cells, usually animals, including humans, and plants, as opposed to a tissue extract or dead organism.
-
DEC 08, 2021 | 11:00 AM
Date: December 8, 2021 Time: 11:00am (PST), 2:00pam (EST) Breast cancer is the most common type of cancer and the leading cause of cancer deaths for women. Despite considerable ongoing resea...DEC 07, 2021 | 8:00 AM
Date: November 7, 2021 Time: 8:00am (PDT), 11:00am (EDT) Analysis of SARS-CoV-2–specific T cells is important to understand their role during acute disease and in long-term protection...OCT 26, 2021 | 8:00 AM
Date: October 26, 2021 Time: 8:00am (PDT), 11:00am (EDT) A complex interaction among heterogenous immune and tumor cells within the tumorous tissue not only influences tumor progression, but...OCT 13, 2021 | 6:00 AM
We’ll discuss the rapid discovery efforts to identify human monoclonal antibody drugs that protect against COVID-19. We will review the technologies used to find antibodies, the optima...OCT 07, 2021 | 10:00 AM
Date: October 07, 2021 Time: 10:00am (PDT), 1:00pm (EDT) It's estimated than less than 10% of investigational anti-cancer drugs successfully achieve FDA approval for clinical use. This i...SEP 29, 2021 | 11:59 PM
Cas9 based therapeutics have the potential to revolutionize the treatment of genetic diseases. However, safe and effective methods for delivering Cas9 protein, gRNA and donor DNA need to be...SEP 29, 2021 | 11:00 AM
Date: Septembr 29, 2021 Time: 11:00am (PDT), 2:00pm (EDT) 3D cell models are becoming increasingly popular for studying complex biological effects, tissue functionality, and diseases. While...SEP 08, 2021 | 8:00 AM
Date: September 08, 2021 Time: 8:00am (PST), 11:00am (EST) Developing biopharmaceuticals is challenging, with safety liability remaining one of the primary reasons for failure. As such, safe...SEP 08, 2021 | 12:00 AM
Self-amplifying RNA replicons are promising candidates for next generation vaccines against human coronaviruses with pandemic potential. Self-amplification of RNAs in host cells generates mo...SEP 08, 2021 | 12:00 AM
For centuries, humans have become infected with endemic circulating Coronaviruses (hCoV), typically repeatedly throughout life. To understand how these respiratory infections establish CD4 T...AUG 25, 2021 | 12:00 AM
Ataxia Telangiectasia, also known as A-T, is a devastating neuropediatric and genetic disorder for which there is no cure. Patients suffer from immune deficiency, cancer predisposition, and...AUG 25, 2021 | 12:00 AM
Over 40 tandem repeats undergo expansion events that lead to neurological disease. This number is likely an underestimate as many repeats are difficult to amplify using existing short read s...Speaker: Paul Valdmanis, PhDAUG 25, 2021 | 12:00 AM
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with multiple motor and non-motor symptoms. PD is characterized by the presence on proteinaceous neuronal...JUN 24, 2021 | 8:00 AM
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...JUN 08, 2021 | 8:00 AM
Date: June 08, 2021 Time: 08:00am (PDT) COVID-19 displays high clinical variability, but what determines its severity is unclear. Analysis of antigen-specific T cell responses has contribu...MAY 11, 2021 | 10:00 AM
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...Speaker: Paulina Kocjan , Kate Meola , Zareh ZurabyanAPR 27, 2021 | 7:00 AM
Date: April 27, 2021 Time: 7:00am (PDT), 11:00am (EDT) Visualization is an important step to address complex biological questions in vivo. The imaging process can widen the perspective of an...FEB 24, 2021 | 1:30 PM
G protein-coupled receptors (GPCRs) are among the most intensively studied drug targets, and account for about ~34% of all drugs approved by the FDA. Examples of drugs targeting GPCRs includ...Speaker: Annette Gilchrist, PhD , Professor Kevin Pfleger, MA, PhD, FBPhS , Juan José Fung, PhD , Aarti Kawatkar , Yamina A. Berchiche, PhD , Ajay Yekkirala, PhDPresented at: Drug Discovery & Development Virtual Event Series 2021
FEB 24, 2021 | 12:00 PM
With an introduction by Sarah Warren, the Senior Director of Translational Science, this webinar will open by providing a brief technology overview of NanoString Technologies. Dr. Warren wil...Speaker: Jason Frazier , Sarah Warren, PhDPresented at: Drug Discovery & Development Virtual Event Series 2021
Sponsored By: NanoString TechnologiesFEB 24, 2021 | 10:00 AM
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...FEB 24, 2021 | 12:00 AM
Platform based therapeutics and vaccines offer a unique opportunity to simplify and streamline the drug development process. Moderna has taken the approach of harnessing the power of mRNA as...Speaker: Joseph J. Senn, PhD, DABTPresented at: Drug Discovery & Development Virtual Event Series 2021
FEB 24, 2021 | 12:00 AM
G-protein-coupled receptors (GPCRs) remain major drug targets, despite an incomplete understanding of how they signal through 16 non-visual G-protein signal transducers (collectively named t...Speaker: Reid Olsen, PhD, Pharmacology, Head of GPCR PharmacologyPresented at: Drug Discovery & Development Virtual Event Series 2021
FEB 10, 2021 | 12:00 AM
Pain management includes the choice of analgesia agents, their dose, administration method, duration and frequency of treatment, and a pain-monitoring scheme for each individual animal. Insu...FEB 10, 2021 | 12:00 AM
There is growing concern about the reliability of biomedical research results. Poor experimental design, inappropriate analysis methods and incomplete reporting have all contributed to incon...
DEC 08, 2021 | 11:00 AM
Date: December 8, 2021 Time: 11:00am (PST), 2:00pam (EST) Breast cancer is the most common type of cancer and the leading cause of cancer deaths for women. Despite considerable ongoing resea...
DEC 07, 2021 | 8:00 AM
Date: November 7, 2021 Time: 8:00am (PDT), 11:00am (EDT) Analysis of SARS-CoV-2–specific T cells is important to understand their role during acute disease and in long-term protection...
OCT 26, 2021 | 8:00 AM
Date: October 26, 2021 Time: 8:00am (PDT), 11:00am (EDT) A complex interaction among heterogenous immune and tumor cells within the tumorous tissue not only influences tumor progression, but...
OCT 13, 2021 | 6:00 AM
We’ll discuss the rapid discovery efforts to identify human monoclonal antibody drugs that protect against COVID-19. We will review the technologies used to find antibodies, the optima...
OCT 07, 2021 | 10:00 AM
Date: October 07, 2021 Time: 10:00am (PDT), 1:00pm (EDT) It's estimated than less than 10% of investigational anti-cancer drugs successfully achieve FDA approval for clinical use. This i...
SEP 29, 2021 | 11:59 PM
Cas9 based therapeutics have the potential to revolutionize the treatment of genetic diseases. However, safe and effective methods for delivering Cas9 protein, gRNA and donor DNA need to be...
SEP 29, 2021 | 11:00 AM
Date: Septembr 29, 2021 Time: 11:00am (PDT), 2:00pm (EDT) 3D cell models are becoming increasingly popular for studying complex biological effects, tissue functionality, and diseases. While...
SEP 08, 2021 | 8:00 AM
Date: September 08, 2021 Time: 8:00am (PST), 11:00am (EST) Developing biopharmaceuticals is challenging, with safety liability remaining one of the primary reasons for failure. As such, safe...
SEP 08, 2021 | 12:00 AM
Self-amplifying RNA replicons are promising candidates for next generation vaccines against human coronaviruses with pandemic potential. Self-amplification of RNAs in host cells generates mo...
SEP 08, 2021 | 12:00 AM
For centuries, humans have become infected with endemic circulating Coronaviruses (hCoV), typically repeatedly throughout life. To understand how these respiratory infections establish CD4 T...
AUG 25, 2021 | 12:00 AM
Ataxia Telangiectasia, also known as A-T, is a devastating neuropediatric and genetic disorder for which there is no cure. Patients suffer from immune deficiency, cancer predisposition, and...
AUG 25, 2021 | 12:00 AM
Over 40 tandem repeats undergo expansion events that lead to neurological disease. This number is likely an underestimate as many repeats are difficult to amplify using existing short read s...
Speaker:
Paul Valdmanis, PhD
AUG 25, 2021 | 12:00 AM
Parkinson’s disease (PD) is the second most common neurodegenerative disorder with multiple motor and non-motor symptoms. PD is characterized by the presence on proteinaceous neuronal...
JUN 24, 2021 | 8:00 AM
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
JUN 08, 2021 | 8:00 AM
Date: June 08, 2021 Time: 08:00am (PDT) COVID-19 displays high clinical variability, but what determines its severity is unclear. Analysis of antigen-specific T cell responses has contribu...
MAY 11, 2021 | 10:00 AM
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
Speaker:
Paulina Kocjan
, Kate Meola
, Zareh Zurabyan
APR 27, 2021 | 7:00 AM
Date: April 27, 2021 Time: 7:00am (PDT), 11:00am (EDT) Visualization is an important step to address complex biological questions in vivo. The imaging process can widen the perspective of an...
FEB 24, 2021 | 1:30 PM
G protein-coupled receptors (GPCRs) are among the most intensively studied drug targets, and account for about ~34% of all drugs approved by the FDA. Examples of drugs targeting GPCRs includ...
Speaker:
Annette Gilchrist, PhD
, Professor Kevin Pfleger, MA, PhD, FBPhS
, Juan José Fung, PhD
, Aarti Kawatkar
, Yamina A. Berchiche, PhD
, Ajay Yekkirala, PhD
Presented at: Drug Discovery & Development Virtual Event Series 2021
FEB 24, 2021 | 12:00 PM
With an introduction by Sarah Warren, the Senior Director of Translational Science, this webinar will open by providing a brief technology overview of NanoString Technologies. Dr. Warren wil...
Speaker:
Jason Frazier
, Sarah Warren, PhD
Presented at: Drug Discovery & Development Virtual Event Series 2021
Sponsored By: NanoString Technologies
Sponsored By: NanoString Technologies
FEB 24, 2021 | 10:00 AM
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
FEB 24, 2021 | 12:00 AM
Platform based therapeutics and vaccines offer a unique opportunity to simplify and streamline the drug development process. Moderna has taken the approach of harnessing the power of mRNA as...
Speaker:
Joseph J. Senn, PhD, DABT
Presented at: Drug Discovery & Development Virtual Event Series 2021
FEB 24, 2021 | 12:00 AM
G-protein-coupled receptors (GPCRs) remain major drug targets, despite an incomplete understanding of how they signal through 16 non-visual G-protein signal transducers (collectively named t...
Speaker:
Reid Olsen, PhD, Pharmacology, Head of GPCR Pharmacology
Presented at: Drug Discovery & Development Virtual Event Series 2021
FEB 10, 2021 | 12:00 AM
Pain management includes the choice of analgesia agents, their dose, administration method, duration and frequency of treatment, and a pain-monitoring scheme for each individual animal. Insu...
FEB 10, 2021 | 12:00 AM
There is growing concern about the reliability of biomedical research results. Poor experimental design, inappropriate analysis methods and incomplete reporting have all contributed to incon...